omega-n-methylarginine has been researched along with Neurodegenerative Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
| Cho, KH; Dhorma, LP; Hah, JM; Kim, MH; Kim, SY; Kumar, DN; Park, HG; Venkanna, A | 1 |
| Khan, Z; Kim, SY; Lee, KR; Park, KJ; Subedi, L | 1 |
1 review(s) available for omega-n-methylarginine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |
2 other study(ies) available for omega-n-methylarginine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone.
Topics: Drug Discovery; Inflammation; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Nitric Oxide; Protein Kinase Inhibitors; Quinones; Spiro Compounds; Structure-Activity Relationship | 2019 |
Antineurodegenerative Labdane Diterpenoid Glycosides from the Twigs of
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Line, Tumor; Diterpenes; Encephalitis; Glycosides; Humans; Lipopolysaccharides; Mice; Microglia; Molecular Structure; Nerve Growth Factor; Neurodegenerative Diseases; Neuroprotective Agents; Nitric Oxide; Pinus; Plant Stems | 2020 |